Sprint Bioscience AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	108.33	126.7	25.06	49.93	29.49	70.64
Cash & Short-Term Investments	108.33	126.7	25.06	49.93	29.49	70.64
Cash Growth	476.68%	405.68%	-49.82%	69.31%	-58.25%	160.92%
Other Receivables	7.12	6.17	12.19	7.94	5.39	5.29
Total Trade Receivables	7.12	6.17	12.19	7.94	5.39	5.29
Total Current Assets	115.45	132.87	37.24	57.87	34.88	75.94
Net Property, Plant & Equipment	3.47	3.74	4.72	4.38	2.37	2.99
Other Long-Term Assets	0.06	0.06	0.1	0.13	0.17	0.21
Total Assets	118.97	136.66	42.06	62.38	37.42	79.14
Accounts Payable	2.4	4.4	5.44	5.71	3.73	2.92
Other Current Liabilities	10.28	13.08	27.34	28.9	5.51	5.76
Total Current Liabilities	12.69	17.48	32.78	34.6	9.23	8.68
Total Liabilities	12.69	17.48	32.78	34.6	9.23	8.68
Common Stock	7.07	7.07	6.98	6.98	6.98	3.98
Additional Paid-in Capital	291.75	291.75	273.67	273.9	273.87	258.97
Retained Earnings	-192.54	-179.65	-271.38	-253.1	-252.67	-192.5
Shareholders' Equity	106.29	119.18	9.27	27.77	28.19	70.45
Total Liabilities & Equity	118.97	136.66	42.06	62.38	37.42	79.14
Net Cash (Debt)	108.33	126.7	25.06	49.93	29.49	70.64
Net Cash Growth	-14.50%	405.68%	-49.82%	69.31%	-58.25%	160.92%
Net Cash Per Share	1.07	1.37	0.36	0.71	0.70	2.45
Book Value	106.29	119.18	9.27	27.77	28.19	70.45
Book Value Per Share	1.05	1.29	0.13	0.40	0.67	2.44
Tangible Book Value	106.29	119.18	9.27	27.77	28.19	70.45
Tangible Book Value Per Share	1.05	1.29	0.13	0.40	0.67	2.44